Several clinical indicators have been identified as risk factors including tumor stage T4, poor tumor grading, elevation of pre-operative carcino-embryonic antigen(CEA), presence of lymphovascular or perineural invasion [7-9]. Here, CEACAM5 is linked to neoplasm.